Biologist Julia Kremenska: Congress of reproductive and embryology in Geneva ESHRE showed new ways of development of ART
In July 2017 an annual Congress of reproductologists and embryologists was held in Geneva, traditionally gathered more than 10 thousand participants from all over Europe, as well as from the USA, Australia, India, China, Japan and other countries of the world. Among the world's leading specialists in reproductive medicine were doctors from ISIDA clinic: Julia Kremenska, a biologist, an embryologist, a molecular geneticist; Palamarchuk Alina, obstetrician-gynecologist, reproductologist; Turban Svetlana Viktorovna, reproductive physician.
Julia Valerievna Kremenska shared her impressions about participation in ESHRE.
Julia Valerievna, what are the goals and objectives of this congress?
ESHRE-2017 is the 33rd Congress, which annually organizes and conducts the European Community of Human Reproduction and Embryology in different countries of the world. This is a very large-scale event, which gives an opportunity, literally, to get the latest information about scientific developments in the field of assisted reproductive technologies. And also you can, in personal communication with the world's experts, discuss those professional problems and issues that are of the greatest interest at the moment.
I want to emphasize also the importance of the large-scale work of the European Community of reproduction on the collection and processing of information on the effectiveness of certain methods of treating infertility. Each clinic, of course, has its own statistics, which allows you to draw certain conclusions, make adjustments to the internal protocols of treatment if necessary. But the data that are in the hands of the specialists of one clinic should be comparable with the data obtained as a result of the analysis of information from almost all the world's clinics specializing in the treatment of infertility. This information is collected, processed and voiced by the European Society of Reproduction. And this is very important and necessary.
You said that ESHRE provides information on the latest scientific developments in the field of reproductology. What did you find most interesting and promising from the speech at the congress?
Personally for me, there were very interesting reports on the robotization of embryology. Working with oocytes and embryos requires a specialist to have great concentration and filigree skill. It is clear that with this level of tension of work, the human factor acquires special significance. The experience of the embryologist, his state of health, mood, fatigue - all these factors are set to zero, if robotics comes instead of a person. ESHRE showed what else can be done in this direction. In ISIDA clinic, we are actively discussing the introduction of such robotic technologies into practice.
For example, information was given about an incubator with an integrated system for assessing embryo development. This device helps even predict the likelihood of pregnancy. Automatic vitrification of embryos and oocytes is another example of robotization in embryology.
Which of the newest techniques and methodswill be implemented in the work of ISIDA clinic?
I want to emphasize: the scientific and practical level of ISIDA clinic is very high. And participation in events like ESHRE, shows that fact very clearly. Listening to the reports, communicating with colleagues from different countries, you understand: we are on the right track, talking with leading experts of the world in one professional language, our experience is of no less interest to them than their achievements – for us.
Therefore, it is incorrect to say that everything heard and seen needs to be immediately introduced into the practice of ISIDA clinic. First, we already have a lot. Secondly, each country, each clinic – has its own unique experience (I'm not saying that every individual case of infertility is unique). And we always need to evaluate and understand how much this or that innovation fits into the national practices in the internal treatment protocols adopted in each clinic. Medical processes are very subtle, because we are dealing with life at the very beginning of its occurrence. Therefore haste is inappropriate here.
In ISIDA clinic adopted the practice: after returning from medical congresses or conferences like ESHRE, doctors make a presentation to their colleagues with suggestions about possible changes in the practical work. If as a result of collective discussion we come to the conclusion that changes are necessary and possible, we certainly do them.
I want to emphasize that none of the modern clinics specializing in the treatment of infertility, can not operate without introducing into its work the latest scientific discoveries. Each physician should be targeted, "programmed" that the patient needs modern approaches to the treatment of his problem for his health and well-being - more sparing, with a high level of guarantees. Yes, for the clinic, the introduction of new scientific developments into practice is always financially costly. But this is being paid off with the happiness of patients.
Kremenska Julia Valerievna, biologist, embryologist, molecular geneticist – candidate of biological sciences PhD, defense of her international thesis was held at the University of Tokyo (Japan). She is the author of several publications in international rating journals (PubMed).
Julia Kremenska worked as a research associate in leading laboratories of the world (Tokyo University, Japan, Agency for Technology, Science and Research, A*STAR, Singapore); headed the cytogenetic laboratory in the clinic of reproductive technologies (2006-2010) with the introduction of modern methods of preimplantation and prenatal molecular diagnostics into practice.
In ISIDA clinic Julia Valerievna Kremenska specializes in embryology, molecular biology, cytogenetics; together with reproductologists, leads patients with severe forms of infertility who have a history of chromosomal and genetic abnormalities, as well as habitual miscarriages and multiple unsuccessful IVF attempts.